Elia Brodsky is the co-founder and CEO of Pine Biotech, a company that specializes in merging big -omics data analysis with clinical care for precision applications in Real World Evidence. With a vision towards improving patient outcomes and providing researchers and clinicians with the tools to have an impact on healthcare, Pine Biotech is at the forefront of research & development of new targets and therapeutics, stratified clinical trials, and development of biomarkers for early detection and companion diagnostics.

Brodsky brings a wealth of experience to her role at Pine Biotech. She studied Design and Visual Communications at Tiltan College, Business Administration and Management at the MATI Small Business Development Center, and graduated from the HBX Business Administration and Management program at Harvard Business School. Additionally, she has a background in Applied Mathematics and College/University Preparatory and Advanced High School/Secondary Diploma Program at Bar-Ilan University.

Prior to co-founding Pine Biotech, Brodsky held various positions including CTO at Local Crowd Fund, International Business Development Manager at The IRON Network, Market Analyst and Partner at HERMES IP SERVICES, Technical Director at Israel Now News, and Motion Graphics and Visual Communications at TA Media. She was also the Creative Director and Project Manager at VidAdBox, an Assistant Video Editor at SuomiTV - Family Channel Oy, and the Media Team Leader at Carmel Assembly.

Brodsky's extensive professional background demonstrates an impressive range of skills, from design and visual communications to technical expertise in big data analysis and business development strategy. She's passionate about making use of cutting-edge technology and data to accelerate research and development in healthcare and improve clinical care.